Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Alembic Pharmaceuticals Limited

Latest From Alembic Pharmaceuticals Limited

Alembic Suffers 38% Slide In US As Price Erosion Bites

India’s Alembic has reported a 38% drop in its US generics business in the first quarter of its FY22 financial, due to price erosion stemming from increased competition. The company plans to launch four generics in the US in the coming quarter.

Generic Drugs Sales & Earnings

Generics Industry Fails To Match Last Year’s Growth In First Quarter

The generics industry struggled with the prior-year comparison as it saw an expected decline in revenues in the first quarter of 2021, driven by the global impact of the COVID-19 crisis. As a result, the performance of most companies fell short of the numbers reported in Q1 2020. However, a few managed to contradict the trend by reporting growth, either based on the launch of COVID-related drugs or performance in specific geographies. 

Sales & Earnings Coronavirus COVID-19

Alembic Reveals Pricing Challenges For US Sartans Amid Competition

Indian firm Alembic Pharmaceuticals discussed the challenges ahead for its US generics business while revealing a dramatic uptick in non-US overseas markets during its FY2021 financial earnings call.

Generic Drugs Pricing Strategies

Will India’s $3bn Incentive Schemes Yield A $41bn Dividend?

An new $2.1bn incentive scheme for formulations follows on from an earlier scheme for APIs in India. Experts weigh in on the likelihood of industry participation and whether this $3bn push will result in $41bn of incremental sales for the industry while strengthening supply chains in a post-COVID world. 

Business Strategies Commercial
See All

Company Information

  • Industry
  • Services
    • Hospitals, Nursing Homes, Institutions
  • Pharmaceuticals
    • Generic Drugs
  • Other Names / Subsidiaries
    • Orit Laboratories Alembic Global Holding SA Aleor Dermaceuticals Limited Alembic Pharmaceuticals Australia Pty Limited Alembic Pharmaceuticals Europe Limited Alembic Pharmaceuticals Inc Alembic Pharmacueticals Canada Limited Alnova Pharmaceuticals SA Genius LLC